The Necessity of Both Allogeneic Antigens and Stem Cells for Cyclophosphamide-Induced Skin Allograft Tolerance in Mice

Immunobiology

Volumn 178, Issue 4-5, 1989, Pages 287-304

  Mayumi, Hisanori ^a   Good, Robert A ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

(viable) bone marrow cells; (viable) spleen cells; 2000R irradiated bone marrow cells; 2000R irradiated spleen cells; AKR; AKR J; analysis of variance; ANOVA; BMC; C3H; C3H HeJ; CBA; CBA J; CP; cyclophosphamide; DBA; DBA 2J; i. v.; i.p.; IBMC; intraperitoneal(ly); intravenous(ly); ISC; mean survival time; MST; SC; SD; standard deviation

Indexed keywords

ALLOANTIGEN; CYCLOPHOSPHAMIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; BIOLOGICAL MODEL; BONE MARROW; HISTOCHEMISTRY; HISTOLOGY; IMMUNOLOGICAL TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TRANSPLANTATION; SPLEEN CELL; STEM CELL; SUPPRESSOR CELL;

ANIMAL; BONE MARROW; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GRAFT SURVIVAL; H-2 ANTIGENS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; IMMUNE TOLERANCE; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED STRAINS; SKIN TRANSPLANTATION; SPLEEN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HOMOLOGOUS;

EID: 0024564789     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(89)80053-1     Document Type: Article

References (65)

1. The influence of 6-mercaptopurine on antibody formation
2. Effect of 6-mercaptopurine on antibody production
3. Drug-induced immunological tolerance
4. Prolongation of skin homograft survival in rabbits by 6-mercaptopurine
5. The effects of 6-mercaptopurine on homograft reactions
6. 6-mercaptopurine in immunological responsiveness
7. The rejection of renal homografts inhibition in dogs by 6-mercaptopurine
8. Induction of tolerance to skin homografts in adult mice treated with 6-mercaptopurine
9. Drug-induced immunological tolerance for homotransplantation
10. Drug-induced immunologic tolerance for homotransplantation of skin
11. The effect of certain alkylating agents and antimetabolites on the primary agglutinin response of rats injected with sheep erythrocytes
12. Effect of cytotoxic agents on antibody production
13. Drug-induced tolerance to allografts in mice. VII. Optimal protocol and mechanism of cyclophosphamide-induced tolerance in an H-2 haplotype-identical strain combination
14. Drug-induced tolerance to allografts in mice. II. Tolerance to tumor allografts of large doses associated with rejection of skin allografts and tumor allografts of small doses
15. Drug-induced tolerance to allografts in mice. IV. Mechanisms and kinetics of cyclophosphamide-induced tolerance
16. Drug-induced tolerance to allografts in mice. VI. Tolerance induction in H-2-haplotype-identical strain combinations in mice
17. Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients
18. Tolerance, restriction and the Mls enigma
19. Drug-induced tolerance to allografts in mice. XIII. Tolerance to the H-Y antigen
20. Some statistical methods useful in circulation research
21. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells
22. Immunologic incompetence of immunologically runted animals
23. Failure of allogeneic canine marrow grafts after total-body irradiation
24. Active clonal deletion in neonatal H-2 tolerance
25. Suppressor cells in transplantation tolerance to self and non-self
26. The identity of suppressor cells in neonatal tolerance
27. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships
28. Analysis of neonatally induced tolerance of H-2 alloantigens. III. Ease of abolition of tolerance of class I, but not class II, antigens with infusions of syngeneic, immunocompetent cells
29. Drug-induced tolerance to allografts in mice. I. Difference between tumor and skin grafts
30. On the mechanism of immunological tolerance in cyclophosphamide-treated mice
31. Inhibition of hemagglutinin synthesis by cytoxan
32. Studies on cyclophosphamide-induced tolerance to sheep erythrocytes
33. Prolongation of homograft survival in mice with single doses of cyclophosphamide
34. Tolerance induction of alloreactivity by portal venous inoculation with allogeneic cells followed by the injection of cyclophosphamide. I. Specific suppression of alloreactive cytotoxic and delayed-type hypersensitivity responses as well as allograft rejection
35. Nucleic acids and the production of antibody by plasma cells
36. Studies on the immunological response to foreign tumor transplants in mouse. III. Changes in the weight, and content of nucleic acids and protein, of host lymphoid tissues
37. Cellular immunity in vitro: clonal proliferation of antigen-stimulated lymphocytes
38. Immunological tolerance induced by cyclophosphamide assayed by plaque spleen cell method
39. Lymphocyte stimulation selective destruction of cells during blastogenic response to transplantation antigens
40. Platelets-cyclophosphamide-induced immunological tolerance to skin allografts in mice
41. Why MHC incompatible grafts induce strong primary alloimmunity
42. Major histocompatibility complex restriction and transplantation immunity a possible solution to the allograft problem
43. Specificity and precursor frequency of cytotoxic T cells in the response to minor H antigens
44. Quantitative studies on tissue transplantation immunity. IV. Induction of tolerance in newborn mice and studies on the phenomenon of runt disease
45. Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice
46. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts
47. Functional clonal deletion versus suppressor cell-induced transplantation tolerance in chimeras prepared with a short course of total-lymphoid irradiation
48. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice
49. The role of donor lymphoid cells in transfer of allograft tolerance
50. Neonatal T cell tolerance to minimal immunogenic peptides is caused by clonal inactivation
51. Membrane and metabolic requirements for tolerance induction of neonatal B cells
52. Mechanisms of specific unresponsiveness to allografts
53. Regulation of immune response. II. Repressor T cells in cyclophosphamide-induced tolerant mice
54. Drug-induced tolerance to allografts in mice. XII. The relationships between tolerance, chimerism, and graft-versus-host disease
55. Monoclonal antibodies specific for interleukin 3-sensitive murine cells
56. Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells
57. Cells in bone marrow and in T colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens
58. Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them
59. The human Ia system: an overview
60. The human Ia system
61. Natural suppressor (NS) cells members of the LGL regulatory family